Hillman Cancer Center / University of Pittsburgh Medical Center

5115 Centre Avenue
Pittsburgh, Pennsylvania 15232

We've found

2 trials

at this facility

Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Pittsburgh, PA

A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Pittsburgh, PA

Use our guide to learn which trials are right for you!